OCT China 2026: China becoming ‘centre of gravity’ in global clinical trial sector
At OCT and CTS China 2026, experts discussed how Chinese biotechs are becoming more central to both the clinical trial sector and the dealmaking environment.
The post OCT China 2026: China becoming ‘centre of gravity’ in global clinical trial sector appeared first on Clinical Trials Arena .